Zynerba Pharmaceuticals (Formerly AllTranz)
Pharmaceutical products via dermal solutions to treat a various neuroscience disorders. Learn more
Launch date
Employees
Market cap
€63.7m
Enterprise valuation
€31m (Public information from Oct 2023)
Share price
$1.3 ZYNE
Easttown Township Pennsylvania (HQ)
Authorizing premium user...